Want to see TSE:RHEL full AI Analyst Report?
Red Light Holland (RHEL) Stock Forecast & Price Target
RHEL Analyst Ratings
There are no analyst ratings in the last 3 months.
RHEL Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts​
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | CAD 0.02 | hold | -5.00%Downside | Reiterated | 11/02/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | CAD 0.02 | sell | -5.00%Downside | Reiterated | 11/02/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | CAD 0.02 | sell | -10.00%Downside | Downgraded | 11/02/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | CAD 0.02 | hold | 0.00%Upside | Reiterated | 11/02/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | CAD 0.02 | sell | -5.00%Downside | Downgraded | 11/02/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | CAD 0.02 | hold | -5.00%Downside | Reiterated | 11/02/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 11/02/26 | CAD 0.02 | hold | -5.00%Downside | Reiterated | TipRanks - PerPlexity | ||
| Google Drug Manufacturers - Specialty and Generic | 11/02/26 | CAD 0.02 | sell | -5.00%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 11/02/26 | CAD 0.02 | sell | -10.00%Downside | Downgraded | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 11/02/26 | CAD 0.02 | hold | 0.00%Upside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 11/02/26 | CAD 0.02 | sell | -5.00%Downside | Downgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 11/02/26 | CAD 0.02 | hold | -5.00%Downside | Reiterated | TipRanks - xAI |
Best Analysts Covering Red Light Holland
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.90% per trade.
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +3.90% per trade.
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +3.90% per trade.
RHEL Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, RHEL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RHEL average Analyst price target in the past 3 months is ―.
RHEL Financial Forecast
RHEL Sales Forecast
Next quarter’s sales forecast for RHEL is CAD 259.93K with a range of ― to ―. The previous quarter’s sales results were CAD 186.07K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
